Milestone Pharmaceuticals MIST
NASDAQ MIST
$1.05 -0.02 (-1.87%)
At close: Sep 10, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Prepaid Assets (2018 - 2026)

Milestone Pharmaceuticals' (MIST) quarterly Prepaid Assets came in at $1.0 million in Q2 2026, up 38.37% on a YoY basis from $748000.0 in Q2 2025, and down 14.46% quarter-over-quarter from $1.2 million in Q1 2026.

Analysis

Milestone Pharmaceuticals (MIST) Prepaid Assets (2018 - 2026) Analysis & Trends

Milestone Pharmaceuticals (MIST) has reported Prepaid Assets for 9 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets rose 38.37% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.0 million (up 38.37% YoY), and the FY2025 full-year result was $1.8 million, down 1.9% from the prior year.
  • Prepaid Assets fell to $1.0 million in Q2 2026 per MIST's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.0 million in Q3 2023 and bottomed at $748000.0 in Q2 2025.
  • Historically, Prepaid Assets has averaged $3.2 million across 5 years, with a median of $2.6 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Prepaid Assets surged 55.84% in 2023, then tumbled 68.28% in 2024.
  • Over 5 years, Prepaid Assets stood at $6.0 million in 2022, then slumped by 47.08% to $3.2 million in 2023, then tumbled by 42.1% to $1.8 million in 2024, then fell by 1.9% to $1.8 million in 2025, then slumped by 42.66% to $1.0 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $1.0 million, $1.2 million, and $1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Milestone Pharmaceuticals 146.32 Mn -25.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.04 Mn
Mar 31, 2026 1.21 Mn
Dec 31, 2025 1.81 Mn
Sep 30, 2025 2.58 Mn
Jun 30, 2025 748,000.00
Mar 31, 2025 2.36 Mn
Dec 31, 2024 1.84 Mn
Sep 30, 2024 2.52 Mn
Jun 30, 2024 1.71 Mn
Mar 31, 2024 2.36 Mn
Dec 31, 2023 3.18 Mn
Sep 30, 2023 6.96 Mn
Jun 30, 2023 5.40 Mn
Mar 31, 2023 5.45 Mn
Dec 31, 2022 6.01 Mn
Sep 30, 2022 5.06 Mn
Jun 30, 2022 3.47 Mn
Mar 31, 2022 4.07 Mn
Dec 31, 2021 4.30 Mn
Sep 30, 2021 5.97 Mn